Other Consolidated Financial Statement Detail (Tables)

6 Months Ended

Jun. 30, 2011

Business and Collaborations [Abstract]

Other income (expense), net

	For the Three Months						For the Six Months
	Ended June 30,						Ended June 30,
(In millions)	2011			2010			2011			2010
Interest income	$	4.3		$	6.7		$	8.0		$	15.6
Interest expense		(8.4	)		(9.0	)		(17.6	)		(17.3	)
Impairments of investments		(5.5	)		(1.2	)		(6.8	)		(17.0	)
Foreign exchange gains (losses), net		(0.6	)		(0.7	)		(1.0	)		0.3
Gain (loss) on sales of investments, net		0.2			6.3			15.5			11.3
Other, net		(1.7	)		(1.1	)		0.1			(0.3	)
Total other income (expense), net	$	(11.7	)	$	1.0		$	(1.8	)	$	(7.4	)

Other current assets

	As of		As of
	June 30,		December 31,
(In millions)	2011		2010
Deferred tax assets	$	66.9	$	112.2
Prepaid taxes		33.1		31.4
Receivable from collaborations		8.8		7.3
Interest receivable		6.1		4.9
Other prepaid expenses		60.1		47.9
Other		26.8		12.1
Total other current assets	$	201.8	$	215.8

Accrued Expenses and Other

	As of		As of
	June 30,		December 31,
(In millions)	2011		2010
Employee compensation and benefits	$	134.3	$	159.7
Revenue-related rebates		112.4		105.3
Restructuring charges		8.9		66.4
Royalties and licensing fees		40.0		45.1
Deferred revenue		59.1		41.3
Collaboration expenses		57.1		31.6
Clinical development expenses		33.7		24.4
Interest payable		21.6		21.6
Construction in progress acrual		13.3		16.4
Current portion of contingent consideration		4.9		11.9
Derivative liability		24.9		12.2
Other		131.1		130.0
Total accrued expenses and other	$	641.3	$	665.9